Precigen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.54 billion, with shareholders equity totaling $83.79 million.
The company employs approximately 680 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Precigen Inc. reported $152.38 million in revenue, generating net income of $24.41 million.
Key financial metrics include a P/E ratio of 62.98, a price-to-book (P/B) ratio of 18.34, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker PGEN.